PROTAC’ing oncoproteins: targeted protein degradation for cancer therapy

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource, 1 online resource.

Language: Englisch

Bibliographic citation: PROTAC’ing oncoproteins: targeted protein degradation for cancer therapy ; volume:22 ; number:1 ; day:30 ; month:3 ; year:2023 ; pages:1-43 ; date:12.2023
Molecular cancer ; 22, Heft 1 (30.3.2023), 1-43, 12.2023

Creator: Kelm, Jeremy M.
Pandey, Deepti S.
Malin, Evan
Kansou, Hussein
Arora, Sahil
Kumar, Raj
Gavande, Navnath S.

Contributor: SpringerLink (Online service)

DOI: 10.1186/s12943-022-01707-5

URN: urn:nbn:de:101:1-2023081521020681755159

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:56 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Kelm, Jeremy M.
Pandey, Deepti S.
Malin, Evan
Kansou, Hussein
Arora, Sahil
Kumar, Raj
Gavande, Navnath S.
SpringerLink (Online service)

Other Objects (12)

Targeted protein degradation of FK506-binding proteins

Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy

Targeted protein degradation in the pathogenesis and therapy of multiple myeloma

Drugging Protein Tyrosine Phosphatases through Targeted Protein Degradation

TransTACs: novel heterobispecific antibodies for targeted protein degradation in cancer therapy

Towards the Targeted Protein Degradation of PRMT1

Advances in targeted degradation of endogenous proteins

Targeted protein degradation via intramolecular bivalent glues

Intrinsic signaling pathways modulate targeted protein degradation

Precise pancreatic cancer therapy through targeted degradation of mutant p53 protein by cerium oxide nanoparticles

Beyond canonical PROTAC: biological targeted protein degradation (bioTPD)

Alkylamine-tethered molecules recruit FBXO22 for targeted protein degradation

Targeted protein degradation of FK506-binding proteins

Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy

Targeted protein degradation in the pathogenesis and therapy of multiple myeloma

Drugging Protein Tyrosine Phosphatases through Targeted Protein Degradation

TransTACs: novel heterobispecific antibodies for targeted protein degradation in cancer therapy

Towards the Targeted Protein Degradation of PRMT1

Advances in targeted degradation of endogenous proteins

Targeted protein degradation via intramolecular bivalent glues

Intrinsic signaling pathways modulate targeted protein degradation

Precise pancreatic cancer therapy through targeted degradation of mutant p53 protein by cerium oxide nanoparticles

Beyond canonical PROTAC: biological targeted protein degradation (bioTPD)

Alkylamine-tethered molecules recruit FBXO22 for targeted protein degradation

Targeted protein degradation of FK506-binding proteins

Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy

Targeted protein degradation in the pathogenesis and therapy of multiple myeloma

Drugging Protein Tyrosine Phosphatases through Targeted Protein Degradation

TransTACs: novel heterobispecific antibodies for targeted protein degradation in cancer therapy

Towards the Targeted Protein Degradation of PRMT1

Advances in targeted degradation of endogenous proteins

Targeted protein degradation via intramolecular bivalent glues

Intrinsic signaling pathways modulate targeted protein degradation

Precise pancreatic cancer therapy through targeted degradation of mutant p53 protein by cerium oxide nanoparticles

Beyond canonical PROTAC: biological targeted protein degradation (bioTPD)

Alkylamine-tethered molecules recruit FBXO22 for targeted protein degradation

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

PROTAC’ing oncoproteins: targeted protein degradation for cancer therapy

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Targeted protein degradation of FK506-binding proteins

Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy

Targeted protein degradation in the pathogenesis and therapy of multiple myeloma

Drugging Protein Tyrosine Phosphatases through Targeted Protein Degradation

TransTACs: novel heterobispecific antibodies for targeted protein degradation in cancer therapy

Towards the Targeted Protein Degradation of PRMT1

Advances in targeted degradation of endogenous proteins

Targeted protein degradation via intramolecular bivalent glues

Intrinsic signaling pathways modulate targeted protein degradation

Precise pancreatic cancer therapy through targeted degradation of mutant p53 protein by cerium oxide nanoparticles

Beyond canonical PROTAC: biological targeted protein degradation (bioTPD)

Alkylamine-tethered molecules recruit FBXO22 for targeted protein degradation

Targeted protein degradation of FK506-binding proteins

Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy

Targeted protein degradation in the pathogenesis and therapy of multiple myeloma

Drugging Protein Tyrosine Phosphatases through Targeted Protein Degradation

TransTACs: novel heterobispecific antibodies for targeted protein degradation in cancer therapy

Towards the Targeted Protein Degradation of PRMT1

Advances in targeted degradation of endogenous proteins

Targeted protein degradation via intramolecular bivalent glues

Intrinsic signaling pathways modulate targeted protein degradation

Precise pancreatic cancer therapy through targeted degradation of mutant p53 protein by cerium oxide nanoparticles

Beyond canonical PROTAC: biological targeted protein degradation (bioTPD)

Alkylamine-tethered molecules recruit FBXO22 for targeted protein degradation

Targeted protein degradation of FK506-binding proteins

Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy

Targeted protein degradation in the pathogenesis and therapy of multiple myeloma

Drugging Protein Tyrosine Phosphatases through Targeted Protein Degradation

TransTACs: novel heterobispecific antibodies for targeted protein degradation in cancer therapy

Towards the Targeted Protein Degradation of PRMT1

Advances in targeted degradation of endogenous proteins

Targeted protein degradation via intramolecular bivalent glues

Intrinsic signaling pathways modulate targeted protein degradation

Precise pancreatic cancer therapy through targeted degradation of mutant p53 protein by cerium oxide nanoparticles

Beyond canonical PROTAC: biological targeted protein degradation (bioTPD)

Alkylamine-tethered molecules recruit FBXO22 for targeted protein degradation

Related objects

Reset password